Highline Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9K Buy
231
+41
+22% +$3.61K ﹤0.01% 441
2026
Q2
$14.9K Sell
190
-10
-5% -$807 ﹤0.01% 454
2026
Q1
$17.3K Sell
200
-96
-32% -$9.2K ﹤0.01% 328
2025
Q4
$28.4K Buy
296
+89
+43% +$8.64K 0.01% 199
2025
Q3
$19.7K Buy
207
+4
+2% +$368 0.01% 279
2025
Q2
$17.7K Hold
203
– – 0.01% 242
2025
Q1
$18.2K Buy
203
+34
+20% +$3.04K 0.01% 219
2024
Q4
$13.5K Sell
169
-136
-45% -$11.8K ﹤0.01% 213
2024
Q3
$27.5K Sell
305
-188
-38% -$15.8K 0.01% 161
2024
Q2
$38.8K Sell
493
-91
-16% -$7.46K 0.01% 141
2024
Q1
$50.9K Sell
584
-114
-16% -$9.7K 0.02% 134
2023
Q4
$57.5K Buy
698
+561
+409% +$42.8K 0.03% 123
2023
Q3
$10.7K Buy
137
+96
+234% +$8.04K 0.01% 181
2023
Q2
$3.61K Hold
41
– – ﹤0.01% 193
2023
Q1
$3.3K Sell
41
-16
-28% -$1.3K ﹤0.01% 198
2022
Q4
$4.43K Buy
57
+16
+39% +$1.3K ﹤0.01% 180
2022
Q3
$3.31K Buy
+41
New +$3.68K ﹤0.01% 182

Other funds holding MDT

Highline Wealth Partners's MDT Position: Q3 2026 in Review

Highline Wealth Partners increased its Medtronic (MDT) stake by 22% in Q3 2026, buying an estimated $3.61K and bringing the position to 231 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Highline Wealth Partners first reported a position in MDT in Q3 2022 and has held it in 17 quarters since. The position peaked at $57.5K in Q4 2023. 1,135 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Highline Wealth Partners held 231 shares of Medtronic worth $19.9K as of Q3 2026.
  • Highline Wealth Partners bought 41 Medtronic shares in Q3 2026, an estimated $3.61K.
  • Medtronic made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #441 holding.
  • Highline Wealth Partners first reported a position in Medtronic in Q3 2022 and has held it in 17 quarters since.
  • Highline Wealth Partners's Medtronic position peaked at $57.5K in Q4 2023.
  • 1,135 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.